tradingkey.logo
tradingkey.logo
Search

Stocks Quotes

Stock quotes focus on the U.S. market data, including indices, sectors, and related U.S. equity instruments.
US30
US30
US30
51754.700+0.06%
SPX500
SPX500
US500
7411.100-0.12%
NAS100
NAS100
NAS100
28416.700-0.56%

Distribution

Latest
History
No Data

Sector

View More

Industrial Goods

+2.80%
Lockheed Martin Corp+10.41%
Unusual Machines Inc+9.71%
Rectitude Holdings Ltd+9.24%

Investment Holding Companies

+1.21%
SUNB.NB+6.96%
Miluna Acquisition Units+6.48%
Inflection Point Acquisition IV Ord Shs Class A+5.70%

Pharmaceuticals & Medical Research

+1.13%
Zhengye Biotechnology Holding Ltd+27.69%
Neuphoria Therapeutics Inc+16.82%
Scisparc Ltd+16.22%

Energy - Fossil Fuels

+1.03%
Vivakor Inc+28.22%
Robin Energy Ltd+26.91%
TMD Energy Ltd+18.60%

Utilities

+0.99%
Sunation Energy Inc+10.17%
SolarMax Technology Inc+6.33%
Ge Vernova Inc+4.83%

Healthcare Services & Equipment

+0.91%
Advanced Biomed Inc+36.49%
Novocure Ltd+28.39%
Acme United Corp+13.57%
No.
Name
Price
Change
Chg %
Total Score
Time
Volume
Turnover
Market Cap
Shares
Amplitude
Volume Ratio
52wk High
52wk Low
Dividends
Div Yield
5D
10D
20D
60D
120D
250D
Year to Date
Watchlist
3241
Envela Corp
Envela Corp
ELA
20.885
-0.455
-2.13%
6.43
114.17K
1.48M
542.25M
25.96M
2.67
0.87
27.590
5.330
0.00
0.00
-0.45%
-7.91%
-21.72%
+17.73%
+40.73%
+250.42%
+56.09%
3242
Beyond Inc
Beyond Inc
BYON
9.440
0.000
0.00%
6.07
0.00
0.00
541.90M
57.41M
6.21
0.81
12.240
3.540
0.00
0.00
-2.68%
+6.67%
+15.69%
+47.27%
+74.81%
-10.35%
+91.48%
3243
Nexxen International Ltd
Nexxen International Ltd
NEXN
9.725
+0.015
+0.15%
6.26
445.64K
3.31M
541.88M
55.72M
4.84
0.80
12.000
5.600
0.00
0.00
-6.31%
+1.09%
+13.61%
+34.51%
+61.28%
-11.67%
+48.70%
3244
Voyager Acquisition Corp
Voyager Acquisition Corp
VACHU
15.500
0.000
0.00%
--
0.00
0.00
541.25M
0.00
0.00
0.01
15.700
10.080
0.00
0.00
-14.60%
+4.01%
+36.08%
+19.32%
+57.75%
+44.86%
+34.90%
3245
Regulus Therapeutics Inc
Regulus Therapeutics Inc
RGLS
8.160
0.000
0.00%
--
0.00
0.00
540.87M
66.28M
1.35
1.37
8.345
0.830
0.00
0.00
-0.49%
-1.69%
+3.42%
+371.68%
+416.46%
+225.10%
+416.46%
3246
Cybin Inc
Cybin Inc
CYBN
8.280
0.000
0.00%
7.08
0.00
0.00
540.66M
26.10M
2.94
0.58
15.550
6.950
0.00
0.00
-0.72%
+22.30%
+39.16%
+32.27%
+10.99%
-22.25%
--
3247
Olympic Steel Inc
Olympic Steel Inc
ZEUS
47.860
0.000
0.00%
6.58
0.00
0.00
538.98M
10.91M
9.95
6.83
52.650
26.320
0.63
1.31
-5.64%
-0.56%
-2.70%
+40.85%
+50.55%
+36.94%
+11.86%
3248
Ranpak Holdings Corp
Ranpak Holdings Corp
PACK
6.300
-0.710
-10.13%
6.68
734.44K
2.40M
538.83M
85.53M
9.55
2.24
7.160
3.200
0.00
0.00
-8.70%
-2.78%
-17.54%
+52.91%
+20.92%
+61.95%
+16.45%
3249
Ennis Inc
Ennis Inc
EBF
21.310
+0.030
+0.14%
7.32
130.93K
1.17M
538.25M
25.26M
1.92
1.12
22.360
16.300
1.00
4.69
-1.84%
+0.47%
+0.38%
+4.46%
+11.28%
+18.13%
+18.32%
3250
Wabash National Corp
Wabash National Corp
WNC
13.310
-0.600
-4.31%
6.35
1.13M
8.26M
538.21M
40.44M
6.14
0.51
12.940
6.630
0.32
2.40
+6.14%
+7.69%
+1.60%
+51.77%
+33.90%
+24.86%
+53.87%
3251
Myriad Genetics Inc
Myriad Genetics Inc
MYGN
5.700
+0.040
+0.71%
6.52
679.24K
2.70M
538.08M
94.40M
3.88
0.93
8.590
3.530
0.00
0.00
-7.92%
-6.56%
+9.20%
+18.01%
+2.89%
+22.58%
-7.32%
3252
Silence Therapeutics PLC
Silence Therapeutics PLC
SLN
11.380
-0.450
-3.80%
6.07
480.13K
3.90M
537.52M
47.23M
5.70
1.08
8.400
4.190
0.00
0.00
+4.21%
+15.42%
+24.24%
+45.52%
+129.44%
+81.21%
+87.17%
3253
Contineum Therapeutics Inc
Contineum Therapeutics Inc
CTNM
14.355
-0.375
-2.55%
7.39
136.47K
1.53M
536.68M
37.39M
5.43
0.67
16.330
3.350
0.00
0.00
+2.46%
-7.09%
+11.97%
+10.68%
-1.68%
+151.84%
+25.59%
3254
Shattuck Labs Inc
Shattuck Labs Inc
STTK
7.080
+0.060
+0.85%
6.31
606.88K
3.16M
535.12M
75.58M
5.05
0.34
8.330
0.712
0.00
0.00
+0.14%
+0.71%
+17.80%
-8.29%
+73.96%
+714.64%
+93.97%
3255
Nuvectis Pharma Inc
Nuvectis Pharma Inc
NVCT
20.160
+0.870
+4.51%
4.60
325.76K
4.32M
534.75M
26.53M
7.46
1.19
13.340
5.550
0.00
0.00
+8.39%
+6.16%
-17.65%
+130.40%
+136.62%
+160.80%
+167.02%
3256
EQV Ventures Acquisition Ord Shs Class A
EQV Ventures Acquisition Ord Shs Class A
FTW
11.990
-0.030
-0.25%
--
50.94K
338.40K
534.42M
44.57M
1.91
0.57
17.038
9.411
0.00
0.00
-1.24%
-1.24%
-0.83%
+14.08%
+13.54%
+14.41%
+14.30%
3257
Dakota Gold Corp
Dakota Gold Corp
DC
4.685
-0.095
-1.99%
5.78
1.24M
3.79M
534.41M
114.07M
4.07
0.89
7.250
3.040
0.00
0.00
+12.62%
+4.11%
+14.55%
-17.37%
-29.65%
+14.83%
-17.52%
3258
Krispy Kreme Inc
Krispy Kreme Inc
DNUT
3.115
-0.055
-1.74%
5.71
2.96M
5.64M
534.39M
171.56M
2.83
1.21
5.730
2.500
0.00
0.00
-8.65%
-8.92%
-16.49%
-22.51%
-0.48%
-27.73%
-22.51%
3259
Euroseas Ltd
Euroseas Ltd
ESEA
75.730
+1.970
+2.67%
6.90
36.29K
1.99M
534.34M
7.06M
3.15
0.73
78.760
37.520
2.80
3.69
+5.58%
+9.79%
+10.94%
+9.09%
+30.57%
+45.94%
+38.70%
3260
Prime Medicine Inc
Prime Medicine Inc
PRME
2.960
-0.130
-4.21%
5.76
2.49M
5.58M
534.32M
180.51M
3.55
0.76
6.940
1.180
0.00
0.00
-8.07%
-30.02%
-5.13%
-19.35%
-28.67%
-31.95%
-14.70%
3261
Lendingtree Inc
Lendingtree Inc
TREE
39.450
-1.940
-4.69%
7.08
180.42K
5.11M
533.91M
13.53M
5.33
0.74
77.345
32.649
0.00
0.00
-15.87%
-14.01%
+3.25%
-18.93%
-32.58%
-21.63%
-25.69%
3262
Brandywine Realty Trust
Brandywine Realty Trust
BDN
3.070
0.000
0.00%
5.71
4.70M
7.03M
533.26M
173.70M
8.14
3.43
4.630
2.470
0.38
12.49
-3.76%
+0.33%
-1.60%
+2.33%
+8.10%
-25.67%
+5.14%
3263
Ooma Inc
Ooma Inc
OOMA
19.320
-0.920
-4.55%
6.58
311.83K
3.12M
531.30M
27.50M
4.96
0.92
21.960
9.793
0.00
0.00
-7.25%
-3.06%
+4.49%
+17.09%
+66.27%
+60.47%
+64.71%
3264
Destiny Tech100 Inc
Destiny Tech100 Inc
DXYZ
24.150
-1.140
-4.51%
--
1.43M
15.73M
530.73M
21.98M
5.77
1.64
72.870
19.710
0.00
0.00
-11.05%
-12.66%
-5.70%
-19.15%
-25.83%
-25.00%
-21.16%
3265
GeoPark Ltd
GeoPark Ltd
GPRK
10.260
-0.050
-0.48%
6.49
287.99K
1.55M
530.07M
51.66M
2.81
0.76
10.505
5.750
0.47
4.59
+7.77%
+4.48%
+11.04%
+11.04%
+20.00%
+49.56%
+38.46%
3266
Similarweb Ltd
Similarweb Ltd
SMWB
6.050
-0.230
-3.66%
6.34
594.91K
1.72M
529.98M
87.60M
6.21
0.50
10.750
2.220
0.00
0.00
-14.18%
-8.19%
+17.25%
+124.91%
+14.15%
-30.86%
-19.23%
3267
Community Healthcare Trust Inc
Community Healthcare Trust Inc
CHCT
18.500
+0.170
+0.93%
6.38
174.93K
1.57M
528.58M
28.57M
2.23
0.69
18.220
13.230
1.89
10.24
-0.43%
+3.87%
+2.61%
+6.44%
+9.34%
+12.80%
+12.67%
3268
NioCorp Developments Ltd
NioCorp Developments Ltd
NB
4.370
-0.110
-2.46%
4.49
1.88M
5.65M
527.78M
120.77M
3.68
0.77
12.580
2.170
0.00
0.00
+0.00%
-4.38%
-5.41%
-26.18%
-32.30%
+37.42%
-17.55%
3269
Crawford & Co
Crawford & Co
CRDa
10.770
+0.080
+0.75%
6.25
32.67K
166.78K
524.43M
48.69M
3.08
0.87
12.100
8.630
0.29
2.73
-2.97%
-2.18%
-7.08%
+1.89%
+1.32%
+2.47%
-4.27%
3270
One Liberty Properties Inc
One Liberty Properties Inc
OLP
24.890
-0.410
-1.62%
6.55
75.77K
946.71K
524.41M
21.07M
2.01
1.01
25.900
19.620
1.80
7.23
-2.16%
+0.36%
+1.47%
+7.84%
+17.63%
+7.52%
+22.67%

Stock Analysis

Intel Q2 Earnings Far Exceed Expectations: 59% Data Center Business Growth, CPUs Becoming AI Era Protagonists Again

TradingKey - As the market continues to question whether Intel (INTC) can truly ride the AI wave, the company’s second-quarter results have provided an answer. After market close on July 23 ET, Intel released its Q2 2026 earnings report, with revenue, earnings, and next-quarter guidance all significantly exceeding Wall Street's previous expectations.

TradingKey2 hours ago
TradingKey - As the market continues to question whether Intel (INTC) can truly ride the AI wave, the company’s second-quarter results have provided an answer. After market close on July 23 ET, Intel released its Q2 2026 earnings report, with revenue, earnings, and next-quarter guidance all significantly exceeding Wall Street's previous expectations.

NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery

TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

TradingKey4 hours ago
TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

Micron (MU) Hits $1,000 on Three Catalysts - Google Capex, Vera Rubin, NAND Shortage

TradingKey - Micron rose 4% to $1,000 on Thursday driven by Google and Tesla's massive AI capex confirming memory demand, Nvidia's Vera Rubin boosting HBM requirements, and TrendForce flagging a NAND shortage. At $996, $992 resistance has been cleared.

TradingKey5 hours ago
TradingKey - Micron rose 4% to $1,000 on Thursday driven by Google and Tesla's massive AI capex confirming memory demand, Nvidia's Vera Rubin boosting HBM requirements, and TrendForce flagging a NAND shortage. At $996, $992 resistance has been cleared.

Japan and South Korea Stocks Open Lower, KOSPI Drops Over 3%, SoftBank Falls Over 5%, SK Hynix and Kioxia Fall Nearly 4%

TradingKey - In early Asian trading on July 24, Japanese and South Korean stock markets opened lower and continued to decline. Influenced by the sharp overnight pullback in US stocks and escalating geopolitical risks in the Middle East, market risk-off sentiment has risen markedly.

TradingKey5 hours ago
TradingKey - In early Asian trading on July 24, Japanese and South Korean stock markets opened lower and continued to decline. Influenced by the sharp overnight pullback in US stocks and escalating geopolitical risks in the Middle East, market risk-off sentiment has risen markedly.

Today’s Market Recap: Oil Breaks $100, Fueling Inflation Fears, as AI Capex Faces Scrutiny and Tesla’s 14% Plunge Drags Down Tech Sector

TradingKey - The market was hit by a double whammy of soaring oil prices and doubts about the return on AI investments sparked by increased capital expenditures at Google(GOOGL) and Tesla(TSLA). The three major U.S. stock indices plummeted. At the close, the Dow Jones Industrial Average fell 0.97% t

TradingKey5 hours ago
TradingKey - The market was hit by a double whammy of soaring oil prices and doubts about the return on AI investments sparked by increased capital expenditures at Google(GOOGL) and Tesla(TSLA). The three major U.S. stock indices plummeted. At the close, the Dow Jones Industrial Average fell 0.97% t

Intel Q2 Net Profit Swings to Profit YoY, Adjusted EPS Doubles Estimates: Revenue Up 25%, After-Hours Shares Rise Over 13%

Intel (INTC) released its second-quarter 2026 financial results after the U.S. market close on July 23, Eastern Time. As of press time, the stock rose 12.44% to $112.7. During the period, Intel's revenue increased by 25% year-on-year to $16.128 billion, significantly exceeding the market expectation of $14.42 billion by approximately 12%. CEO Lip-Bu Tan stated that this marked the company's strongest quarterly revenue growth in over fifteen years, driven by increased speed, stronger execution, and customer focus.

TradingKey9 hours ago
Intel (INTC) released its second-quarter 2026 financial results after the U.S. market close on July 23, Eastern Time. As of press time, the stock rose 12.44% to $112.7. During the period, Intel's revenue increased by 25% year-on-year to $16.128 billion, significantly exceeding the market expectation of $14.42 billion by approximately 12%. CEO Lip-Bu Tan stated that this marked the company's strongest quarterly revenue growth in over fifteen years, driven by increased speed, stronger execution, and customer focus.

TradingKey SmartPicks

Upcoming Events

Earnings

Dividends

Stock Splits

IPO

Market Heatmap

Stocks

Sector

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.